Blueprint Medicines Corp financial data

Symbol
BPMC on Nasdaq
Industry
Pharmaceutical Preparations
Location
45 Sidney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 362 % -26.6%
Quick Ratio 8.61 % -22.9%
Debt-to-equity 318 % +37.3%
Return On Equity -47.7 % +69%
Return On Assets -11.4 % +75.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.5M shares +4.5%
Common Stock, Shares, Outstanding 63.5M shares +4.47%
Entity Public Float 3.8B USD +26.6%
Common Stock, Value, Issued 63K USD +3.28%
Weighted Average Number of Shares Outstanding, Basic 63.4M shares +4.44%
Weighted Average Number of Shares Outstanding, Diluted 63.4M shares +4.44%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 353M USD -21.6%
Costs and Expenses 710M USD -4.93%
Nonoperating Income (Expense) 149M USD -55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -127M USD +76.9%
Income Tax Expense (Benefit) 616K USD -68.3%
Net Income (Loss) Attributable to Parent -128M USD +76.9%
Earnings Per Share, Basic -2.07 USD/shares +77.5%
Earnings Per Share, Diluted -2.12 USD/shares +76.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 89.4M USD +59.6%
Accounts Receivable, after Allowance for Credit Loss, Current 65.8M USD +61.1%
Inventory, Net 12.5M USD -23.9%
Assets, Current 855M USD +5.78%
Property, Plant and Equipment, Net 37.9M USD -6.82%
Operating Lease, Right-of-Use Asset 66.4M USD -11.7%
Other Assets, Noncurrent 52.2M USD +76.4%
Assets 1.2B USD +8.54%
Accounts Payable, Current 4.72M USD -32.3%
Employee-related Liabilities, Current 40.3M USD +16.7%
Accrued Liabilities, Current 131M USD +18.5%
Contract with Customer, Liability, Current 4.12M USD +36.8%
Liabilities, Current 258M USD +30.5%
Contract with Customer, Liability, Noncurrent 7.92M USD +58.3%
Operating Lease, Liability, Noncurrent 71.9M USD -14.4%
Other Liabilities, Noncurrent 6.17M USD +98.9%
Liabilities 887M USD -1.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.07M USD +60.1%
Retained Earnings (Accumulated Deficit) -2.36B USD -5.75%
Stockholders' Equity Attributable to Parent 313M USD +54.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 313M USD +54.6%
Liabilities and Equity 1.2B USD +8.54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -102M USD +17.4%
Net Cash Provided by (Used in) Financing Activities 67M USD
Net Cash Provided by (Used in) Investing Activities 77.1M USD -55.4%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 63.5M shares +4.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 49.8M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 101M USD +53.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14.3M USD +102%
Deferred Tax Assets, Valuation Allowance 775M USD +23.9%
Deferred Tax Assets, Gross 800M USD +22.7%
Operating Lease, Liability 93.7M USD -9.37%
Payments to Acquire Property, Plant, and Equipment 1.1M USD -57.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -126M USD +76.7%
Lessee, Operating Lease, Liability, to be Paid 116M USD -12.7%
Property, Plant and Equipment, Gross 80.5M USD +24.5%
Operating Lease, Liability, Current 13M USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.8M USD +3.37%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.2M USD +2.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.9M USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.3M USD +3.73%
Deferred Tax Assets, Operating Loss Carryforwards 233M USD +20.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 19.8M USD +3.77%
Operating Lease, Payments 4.55M USD +3.2%
Additional Paid in Capital 2.67B USD +9.74%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.81M USD +30.6%
Share-based Payment Arrangement, Expense 103M USD +7.18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%